ID   ANGP2_MOUSE             Reviewed;         496 AA.
AC   O35608; Q3U1A1; Q9D2D2;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   26-APR-2004, sequence version 2.
DT   07-APR-2021, entry version 167.
DE   RecName: Full=Angiopoietin-2;
DE            Short=ANG-2;
DE   Flags: Precursor;
GN   Name=Angpt2; Synonyms=Agpt2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Uterus;
RX   PubMed=9204896; DOI=10.1126/science.277.5322.55;
RA   Maisonpierre P.C., Suri C., Jones P.F., Bartunkova S., Wiegand S.J.,
RA   Radziejewski C., Compton D.L., McClain J., Aldrich T.H., Papadopoulos N.,
RA   Daly T.J., Davis S., Sato T.N., Yancopoulos G.D.;
RT   "Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo
RT   angiogenesis.";
RL   Science 277:55-60(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and NOD; TISSUE=Head, Ovary, Spleen, and Uterus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Binds to TEK/TIE2, competing for the ANGPT1 binding site, and
CC       modulating ANGPT1 signaling. Can induce tyrosine phosphorylation of
CC       TEK/TIE2 in the absence of ANGPT1. In the absence of angiogenic
CC       inducers, such as VEGF, ANGPT2-mediated loosening of cell-matrix
CC       contacts may induce endothelial cell apoptosis with consequent vascular
CC       regression. In concert with VEGF, it may facilitate endothelial cell
CC       migration and proliferation, thus serving as a permissive angiogenic
CC       signal (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with TEK/TIE2, competing for the same binding site
CC       as ANGPT1. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed only at sites of vascular remodeling.
CC   -!- DOMAIN: The Fibrinogen C-terminal domain mediates interaction with the
CC       TEK/TIE2 receptor. {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF004326; AAB63189.1; -; mRNA.
DR   EMBL; AK019860; BAB31887.1; -; mRNA.
DR   EMBL; AK048622; BAC33396.1; -; mRNA.
DR   EMBL; AK156132; BAE33599.1; -; mRNA.
DR   EMBL; BC027216; AAH27216.1; -; mRNA.
DR   CCDS; CCDS22125.1; -.
DR   RefSeq; NP_031452.2; NM_007426.4.
DR   SMR; O35608; -.
DR   IntAct; O35608; 1.
DR   STRING; 10090.ENSMUSP00000033846; -.
DR   GlyGen; O35608; 6 sites.
DR   iPTMnet; O35608; -.
DR   MetOSite; O35608; -.
DR   PhosphoSitePlus; O35608; -.
DR   MaxQB; O35608; -.
DR   PaxDb; O35608; -.
DR   PRIDE; O35608; -.
DR   ProteomicsDB; 296293; -.
DR   Antibodypedia; 4319; 630 antibodies.
DR   Ensembl; ENSMUST00000033846; ENSMUSP00000033846; ENSMUSG00000031465.
DR   GeneID; 11601; -.
DR   KEGG; mmu:11601; -.
DR   UCSC; uc009kzu.2; mouse.
DR   CTD; 285; -.
DR   MGI; MGI:1202890; Angpt2.
DR   eggNOG; KOG2579; Eukaryota.
DR   GeneTree; ENSGT00940000158430; -.
DR   HOGENOM; CLU_038628_3_1_1; -.
DR   InParanoid; O35608; -.
DR   OMA; LPETDNC; -.
DR   OrthoDB; 357340at2759; -.
DR   PhylomeDB; O35608; -.
DR   TreeFam; TF336658; -.
DR   Reactome; R-MMU-210993; Tie2 Signaling.
DR   BioGRID-ORCS; 11601; 1 hit in 55 CRISPR screens.
DR   PRO; PR:O35608; -.
DR   Proteomes; UP000000589; Chromosome 8.
DR   RNAct; O35608; protein.
DR   Bgee; ENSMUSG00000031465; Expressed in decidua and 221 other tissues.
DR   ExpressionAtlas; O35608; baseline and differential.
DR   Genevisible; O35608; MM.
DR   GO; GO:0042995; C:cell projection; ISO:MGI.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IBA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; HDA:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0048019; F:receptor antagonist activity; TAS:MGI.
DR   GO; GO:0030971; F:receptor tyrosine kinase binding; ISO:MGI.
DR   GO; GO:0005102; F:signaling receptor binding; IBA:GO_Central.
DR   GO; GO:0005172; F:vascular endothelial growth factor receptor binding; TAS:MGI.
DR   GO; GO:0001525; P:angiogenesis; IGI:MGI.
DR   GO; GO:0031100; P:animal organ regeneration; IEA:Ensembl.
DR   GO; GO:0048514; P:blood vessel morphogenesis; IMP:MGI.
DR   GO; GO:0001974; P:blood vessel remodeling; TAS:DFLAT.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl.
DR   GO; GO:0007492; P:endoderm development; TAS:MGI.
DR   GO; GO:0010467; P:gene expression; ISO:MGI.
DR   GO; GO:0007281; P:germ cell development; IEA:Ensembl.
DR   GO; GO:0072012; P:glomerulus vasculature development; ISO:MGI.
DR   GO; GO:0030097; P:hemopoiesis; TAS:DFLAT.
DR   GO; GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IDA:MGI.
DR   GO; GO:0043537; P:negative regulation of blood vessel endothelial cell migration; ISO:MGI.
DR   GO; GO:0010812; P:negative regulation of cell-substrate adhesion; IDA:MGI.
DR   GO; GO:0050928; P:negative regulation of positive chemotaxis; ISO:MGI.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISO:MGI.
DR   GO; GO:0045765; P:regulation of angiogenesis; TAS:DFLAT.
DR   GO; GO:0014823; P:response to activity; IEA:Ensembl.
DR   GO; GO:0009749; P:response to glucose; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0009314; P:response to radiation; IEA:Ensembl.
DR   GO; GO:0048014; P:Tie signaling pathway; ISO:MGI.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:MGI.
DR   CDD; cd00087; FReD; 1.
DR   Gene3D; 3.90.215.10; -; 1.
DR   Gene3D; 4.10.530.10; -; 1.
DR   InterPro; IPR028844; Ang-2.
DR   InterPro; IPR036056; Fibrinogen-like_C.
DR   InterPro; IPR014716; Fibrinogen_a/b/g_C_1.
DR   InterPro; IPR014715; Fibrinogen_a/b/g_C_2.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR020837; Fibrinogen_CS.
DR   PANTHER; PTHR19143:SF199; PTHR19143:SF199; 1.
DR   Pfam; PF00147; Fibrinogen_C; 1.
DR   SMART; SM00186; FBG; 1.
DR   SUPFAM; SSF56496; SSF56496; 1.
DR   PROSITE; PS00514; FIBRINOGEN_C_1; 1.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
PE   2: Evidence at transcript level;
KW   Angiogenesis; Calcium; Coiled coil; Developmental protein; Differentiation;
KW   Disulfide bond; Glycoprotein; Metal-binding; Reference proteome; Secreted;
KW   Signal.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   CHAIN           19..496
FT                   /note="Angiopoietin-2"
FT                   /id="PRO_0000009114"
FT   DOMAIN          275..495
FT                   /note="Fibrinogen C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   COILED          159..256
FT                   /evidence="ECO:0000255"
FT   METAL           429
FT                   /note="Calcium"
FT                   /evidence="ECO:0000250|UniProtKB:O15123"
FT   METAL           431
FT                   /note="Calcium"
FT                   /evidence="ECO:0000250|UniProtKB:O15123"
FT   METAL           433
FT                   /note="Calcium; via carbonyl oxygen"
FT                   /evidence="ECO:0000250|UniProtKB:O15123"
FT   METAL           435
FT                   /note="Calcium; via carbonyl oxygen"
FT                   /evidence="ECO:0000250|UniProtKB:O15123"
FT   CARBOHYD        89
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        119
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        133
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        151
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        240
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        304
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        284..313
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   DISULFID        433..435
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   DISULFID        437..450
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   CONFLICT        348
FT                   /note="S -> N (in Ref. 1; AAB63189)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        411
FT                   /note="G -> A (in Ref. 1; AAB63189)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   496 AA;  56576 MW;  E7563B498A0EF331 CRC64;
     MWQIIFLTFG WDLVLASAYS NFRKSVDSTG RRQYQVQNGP CSYTFLLPET DSCRSSSSPY
     MSNAVQRDAP LDYDDSVQRL QVLENILENN TQWLMKLENY IQDNMKKEMV EIQQNVVQNQ
     TAVMIEIGTS LLNQTAAQTR KLTDVEAQVL NQTTRLELQL LQHSISTNKL EKQILDQTSE
     INKLQNKNSF LEQKVLDMEG KHSEQLQSMK EQKDELQVLV SKQSSVIDEL EKKLVTATVN
     NSLLQKQQHD LMETVNSLLT MMSSPNSKSS VAIRKEEQTT FRDCAEIFKS GLTTSGIYTL
     TFPNSTEEIK AYCDMDVGGG GWTVIQHRED GSVDFQRTWK EYKEGFGSPL GEYWLGNEFV
     SQLTGQHRYV LKIQLKDWEG NEAHSLYDHF YLAGEESNYR IHLTGLTGTA GKISSISQPG
     SDFSTKDSDN DKCICKCSQM LSGGWWFDAC GPSNLNGQYY PQKQNTNKFN GIKWYYWKGS
     GYSLKATTMM IRPADF
//
